Filaria – river blindness
Our R&D portfolio for filarial diseases
What we have achieved
We have built a portfolio of four R&D projects for river blindness and are pursuing the pre-clinical development of drug candidates.
What we are doing for people with river blindness
We aim to complete development and register at least one new drug for river blindness. We are also seeking to identify potential new drug candidates by evaluating registered drugs, as well as pre-clinical and clinical drug candidates to populate the empty drug pipeline.
Building capacity, uniting expertise
Initiatives to utilize and strengthen research capacities in low- and middle-income countries and support networks of excellence to sustain public-interest R&D are central to our virtual R&D model.
Partnering for patients
Collaboration is an essential part of how we work. We have forged a diverse range of alliances and research collaborations with over 200 partners in more than 40 countries.
Get our latest news, personal stories, research articles, and job opportunities.